These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 33066042)

  • 1. Sphingosine-1-Phosphate Receptor Modulators and Oligodendroglial Cells: Beyond Immunomodulation.
    Roggeri A; Schepers M; Tiane A; Rombaut B; van Veggel L; Hellings N; Prickaerts J; Pittaluga A; Vanmierlo T
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33066042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deconstructing the Pharmacological Contribution of Sphingosine-1 Phosphate Receptors to Mouse Models of Multiple Sclerosis Using the Species Selectivity of Ozanimod, a Dual Modulator of Human Sphingosine 1-Phosphate Receptor Subtypes 1 and 5.
    Selkirk JV; Dines KC; Yan YG; Ching N; Dalvie D; Biswas S; Bortolato A; Schkeryantz JM; Lopez C; Ruiz I; Hargreaves R
    J Pharmacol Exp Ther; 2021 Dec; 379(3):386-399. PubMed ID: 34535564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fingolimod downregulates brain sphingosine-1-phosphate receptor 1 levels but does not promote remyelination or neuroprotection in the cuprizone model.
    Nystad AE; Lereim RR; Wergeland S; Oveland E; Myhr KM; Bø L; Torkildsen Ø
    J Neuroimmunol; 2020 Feb; 339():577091. PubMed ID: 31739156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oligodendrocyte progenitor cell recruitment and remyelination in multiple sclerosis: the more, the merrier?
    Tepavčević V; Lubetzki C
    Brain; 2022 Dec; 145(12):4178-4192. PubMed ID: 36093726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sphingosine 1-phosphate receptor modulators in multiple sclerosis and other conditions.
    McGinley MP; Cohen JA
    Lancet; 2021 Sep; 398(10306):1184-1194. PubMed ID: 34175020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nudging oligodendrocyte intrinsic signaling to remyelinate and repair: Estrogen receptor ligand effects.
    Khalaj AJ; Hasselmann J; Augello C; Moore S; Tiwari-Woodruff SK
    J Steroid Biochem Mol Biol; 2016 Jun; 160():43-52. PubMed ID: 26776441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo.
    Najm FJ; Madhavan M; Zaremba A; Shick E; Karl RT; Factor DC; Miller TE; Nevin ZS; Kantor C; Sargent A; Quick KL; Schlatzer DM; Tang H; Papoian R; Brimacombe KR; Shen M; Boxer MB; Jadhav A; Robinson AP; Podojil JR; Miller SD; Miller RH; Tesar PJ
    Nature; 2015 Jun; 522(7555):216-20. PubMed ID: 25896324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The sphingosine-1-phosphate receptor 1 modulator ponesimod repairs cuprizone-induced demyelination and induces oligodendrocyte differentiation.
    Willems E; Schepers M; Piccart E; Wolfs E; Hellings N; Ait-Tihyaty M; Vanmierlo T
    FASEB J; 2024 Jan; 38(2):e23413. PubMed ID: 38243760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oligodendroglial lineage cells express nuclear p57kip2 in multiple sclerosis lesions.
    Pfeifenbring S; Metz I; Kremer D; Küry P; Hartung HP; Brück W
    Glia; 2013 Aug; 61(8):1250-60. PubMed ID: 23828667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oligodendrocytes in Development, Myelin Generation and Beyond.
    Kuhn S; Gritti L; Crooks D; Dombrowski Y
    Cells; 2019 Nov; 8(11):. PubMed ID: 31726662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An update on the use of sphingosine 1-phosphate receptor modulators for the treatment of relapsing multiple sclerosis.
    Dumitrescu L; Papathanasiou A; Coclitu C; Garjani A; Evangelou N; Constantinescu CS; Popescu BO; Tanasescu R
    Expert Opin Pharmacother; 2023 Mar; 24(4):495-509. PubMed ID: 36946625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting CXCR7/ACKR3 as a therapeutic strategy to promote remyelination in the adult central nervous system.
    Williams JL; Patel JR; Daniels BP; Klein RS
    J Exp Med; 2014 May; 211(5):791-9. PubMed ID: 24733828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visualizing Sphingosine-1-Phosphate Receptor 1(S1P
    Hashemi E; Yoseph E; Tsai HC; Moreno M; Yeh LH; Mehta SB; Kono M; Proia R; Han MH
    Cell Mol Neurobiol; 2023 Apr; 43(3):1219-1236. PubMed ID: 35917044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The response of NG2-expressing oligodendrocyte progenitors to demyelination in MOG-EAE and MS.
    Reynolds R; Dawson M; Papadopoulos D; Polito A; Di Bello IC; Pham-Dinh D; Levine J
    J Neurocytol; 2002; 31(6-7):523-36. PubMed ID: 14501221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical discovery and development of fingolimod for the treatment of multiple sclerosis.
    Volpi C; Orabona C; Macchiarulo A; Bianchi R; Puccetti P; Grohmann U
    Expert Opin Drug Discov; 2019 Nov; 14(11):1199-1212. PubMed ID: 31389262
    [No Abstract]   [Full Text] [Related]  

  • 16. Myelin regulatory factor drives remyelination in multiple sclerosis.
    Duncan GJ; Plemel JR; Assinck P; Manesh SB; Muir FGW; Hirata R; Berson M; Liu J; Wegner M; Emery B; Moore GRW; Tetzlaff W
    Acta Neuropathol; 2017 Sep; 134(3):403-422. PubMed ID: 28631093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sphingosine 1-phosphate Receptor Modulator Therapy for Multiple Sclerosis: Differential Downstream Receptor Signalling and Clinical Profile Effects.
    Chun J; Giovannoni G; Hunter SF
    Drugs; 2021 Feb; 81(2):207-231. PubMed ID: 33289881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of Tuberous Sclerosis Complex1 in Adult Oligodendrocyte Progenitor Cells Enhances Axon Remyelination and Increases Myelin Thickness after a Focal Demyelination.
    McLane LE; Bourne JN; Evangelou AV; Khandker L; Macklin WB; Wood TL
    J Neurosci; 2017 Aug; 37(31):7534-7546. PubMed ID: 28694334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular and neuroimmune pharmacology of S1P receptor modulators and other disease-modifying therapies for multiple sclerosis.
    Kihara Y; Chun J
    Pharmacol Ther; 2023 Jun; 246():108432. PubMed ID: 37149155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible regenerative effects of fingolimod (FTY720) in multiple sclerosis disease: An overview on remyelination process.
    Yazdi A; Ghasemi-Kasman M; Javan M
    J Neurosci Res; 2020 Mar; 98(3):524-536. PubMed ID: 31385341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.